Literature DB >> 22365522

Improving outcomes for retroperitoneal sarcomas: a work in progress.

Carol J Swallow1, Charles N Catton.   

Abstract

This article presents the current understanding of prognostic factors and outcomes for retroperitoneal sarcoma. The discussion focuses on the literature published since 2000, including studies with cohorts of at least 30 patients. An interpretation of factors that have contributed to an improvement in outcomes has been performed. With demonstration of the potential for good long-term outcomes and a better appreciation for the importance of minimizing treatment-related morbidity, the international sarcoma community has increasingly recognized and emphasized the importance of expert multidisciplinary assessment and care for this rare malignancy. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22365522     DOI: 10.1016/j.soc.2012.01.002

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  8 in total

Review 1.  Soft tissue sarcoma and radiation therapy advances, impact on toxicity.

Authors:  Nancy El-Bared; Philip Wong; Dian Wang
Journal:  Curr Treat Options Oncol       Date:  2015-05

2.  Surgical outcome and patterns of recurrence for retroperitoneal sarcoma at a single centre.

Authors:  H D J Hogg; D M Manas; D Lee; P Dildey; J Scott; J Lunec; J J French
Journal:  Ann R Coll Surg Engl       Date:  2016-02-14       Impact factor: 1.891

3.  Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists.

Authors:  Elizabeth H Baldini; Ross A Abrams; Walter Bosch; David Roberge; Rick L M Haas; Charles N Catton; Daniel J Indelicato; Jeffrey R Olsen; Curtiland Deville; Yen-Lin Chen; Steven E Finkelstein; Thomas F DeLaney; Dian Wang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-05-01       Impact factor: 7.038

Review 4.  Combining targeted agents with modern radiotherapy in soft tissue sarcomas.

Authors:  Philip Wong; Peter Houghton; David G Kirsch; Steven E Finkelstein; Arta M Monjazeb; Meng Xu-Welliver; Adam P Dicker; Mansoor Ahmed; Bhadrasain Vikram; Beverly A Teicher; C Norman Coleman; Mitchell Machtay; Walter J Curran; Dian Wang
Journal:  J Natl Cancer Inst       Date:  2014-10-18       Impact factor: 13.506

5.  Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists.

Authors:  Elizabeth H Baldini; Walter Bosch; John M Kane; Ross A Abrams; Kilian E Salerno; Curtiland Deville; Chandrajit P Raut; Ivy A Petersen; Yen-Lin Chen; John T Mullen; Keith W Millikan; Giorgos Karakousis; Michael L Kendrick; Thomas F DeLaney; Dian Wang
Journal:  Ann Surg Oncol       Date:  2015-05-28       Impact factor: 5.344

6.  Intraoperative electron radiation therapy as an important treatment modality in retroperitoneal sarcoma.

Authors:  Raeshell S Sweeting; Allison M Deal; Omar H Llaguna; Brian K Bednarski; Michael O Meyers; Jen Jen Yeh; Benjamin F Calvo; Joel E Tepper; Hong Jin Kim
Journal:  J Surg Res       Date:  2013-05-29       Impact factor: 2.192

Review 7.  [Retroperitoneal tumors].

Authors:  O Schmalz
Journal:  Urologe A       Date:  2016-06       Impact factor: 0.639

8.  Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas.

Authors:  Yosuke Morizawa; Makito Miyake; Keiji Shimada; Shunta Hori; Yoshihiro Tatsumi; Yasushi Nakai; Satoshi Anai; Nobumichi Tanaka; Noboru Konishi; Kiyohide Fujimoto
Journal:  World J Surg Oncol       Date:  2016-02-24       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.